{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:13:13Z","timestamp":1789668793960,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001275","name":"The Oak Foundation USA","doi-asserted-by":"publisher","award":["OFIL-24\\u2013074"],"award-info":[{"award-number":["OFIL-24\\u2013074"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN 156267"],"award-info":[{"award-number":["FRN 156267"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004196","name":"Odense Universitetshospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.semarthrit.2026.152983","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T14:50:05Z","timestamp":1776610205000},"page":"152983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9300-7281","authenticated-orcid":false,"given":"Dorthe B.","family":"Berthelsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Haugegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M.","family":"Kamso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Tugwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee S.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.A.","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Flurey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Boers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Voshaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Furst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasvinder A.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thasia","family":"Woodworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen S.","family":"Hazlewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6600-0631","authenticated-orcid":false,"given":"Robin","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2026.152983_bib0001","unstructured":"ICH Guidelines. E2A Clinical Safety Data Management: definitions and standards for expedited reporting. [Internet]. [cited 2025 Feb 3]. Available from: https:\/\/www.ich.org\/page\/efficacy-guidelines."},{"key":"10.1016\/j.semarthrit.2026.152983_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2023.04.005","article-title":"CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials","author":"Junqueira","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.semarthrit.2026.152983_bib0003","article-title":"CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","year":"2025","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152983_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014603","article-title":"Patient perceptions of glucocorticoid side effects: a cross-sectional survey of users in an online health community","volume":"7","author":"Costello","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.semarthrit.2026.152983_bib0005","series-title":"Patient-Reported outcome measures: use in medical product developement to support labeling claims: u.s","year":"2009"},{"issue":"38","key":"10.1016\/j.semarthrit.2026.152983_bib0006","article-title":"OMERACT: an international initiative to improve outcome measurement in rheumatology","volume":"8","author":"Tugwell","year":"2007","journal-title":"Trials"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.152983_bib0007","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jclinepi.2013.11.013","article-title":"Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0","volume":"67","author":"Boers","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.152983_bib0008","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3899\/jrheum.181096","article-title":"OMERACT filter 2.1: elaboration of the Conceptual framework for outcome measurement in Health intervention studies","volume":"46","author":"Boers","year":"2019","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152983_bib0009","first-page":"868","article-title":"Outcomes from the patient perspective workshop at OMERACT 6","volume":"30","author":"Kirwan","year":"2003","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152983_bib0010","first-page":"213","article-title":"The predictors of and reasons for non-adherence in an observational cohort of patients with rheumatoid arthritis commencing methotrexate","volume":"59","author":"Hope","year":"2020","journal-title":"Rheumatol Oxf Engl"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.152983_bib0011","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3899\/jrheum.190196","article-title":"Identifying possible outcome domains from existing outcome measures to inform an OMERACT core domain set for safety in rheumatology trials","volume":"46","author":"Klokker","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152983_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152288","article-title":"Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: outcome of the OMERACT safety working group","volume":"63","author":"Berthelsen","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152983_bib0013","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/cncr.31133","article-title":"Validity and usefulness of a single-item measure of patient-reported bother from side effects of cancer therapy","volume":"124","author":"Pearman","year":"2018","journal-title":"Cancer."},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152983_bib0014","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.152983_bib0015","first-page":"2929","article-title":"COSMIN guideline for systematic reviews of patient-reported outcome measures version 2.0","volume":"33","author":"Mokkink","year":"2024","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"key":"10.1016\/j.semarthrit.2026.152983_bib0016","unstructured":"Mokkink L.B., Elsman E., Terwee C.B. Conducting a systematic review of patient-reported outcome measures. Manual version 2.0 [Internet]. Available from: https:\/\/www.cosmin.nl\/wp-content\/uploads\/COSMIN-manual-V2_final.pdf."},{"issue":"12","key":"10.1016\/j.semarthrit.2026.152983_bib0017","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3899\/jrheum.161105","article-title":"Developing an OMERACT core outcome set for assessing safety components in rheumatology trials: the OMERACT safety working group","volume":"44","author":"Klokker","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152983_bib0018","article-title":"I couldn\u2019t carry on taking a drug like that\u201d: a qualitative study of patient perspectives on side effects from rheumatology drugs","author":"Berthelsen","year":"2024","journal-title":"Rheumatol Oxf Engl"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152983_bib0019","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jama.1968.03150050051011","article-title":"Signs and symptoms","volume":"206","author":"King","year":"1968","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2026.152983_bib0020","unstructured":"Beaton D., Maxwell L., Grosskleg S., Shea B.J., Tugwell P., Bingham C., et al. OMERACT handbook . chapter 5: instrument selection for core outcome sets [Internet]. [cited 2025 Jul 4]. Available from: https:\/\/omeract.org\/handbook\/."},{"key":"10.1016\/j.semarthrit.2026.152983_bib0021","unstructured":"OMERACT: Good methods check with e&e [Internet]. [cited 2025 Jul 4]. Available from: https:\/\/omeract.org\/resources\/downloadable-forms\/."},{"key":"10.1016\/j.semarthrit.2026.152983_bib0022","unstructured":"OMERACT: Summary table reporting evidence of construct validity using correlation with other measures for OMERACT filter 2.3 [Internet]. [cited 2025 Jul 4]. Available from: https:\/\/omeract.org\/resources\/downloadable-forms\/."},{"issue":"7","key":"10.1016\/j.semarthrit.2026.152983_bib0023","first-page":"1901","article-title":"Consensus group. COSMIN reporting guideline for studies on measurement properties of patient\u2011reported outcome measures: version 2.0","volume":"34","author":"Gagnier","year":"2025","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.152983_bib0024","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3899\/jrheum.210688","article-title":"Frequency of symptomatic adverse events in rheumatoid arthritis: an exploratory online survey","volume":"49","author":"Hazlewood","year":"2022","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152983_bib0025","unstructured":"PRO-CTCAE\u00ae quick guide to the item library [Internet]. [cited 2025 Apr 3]. Available from: https:\/\/healthcaredelivery.cancer.gov\/pro-ctcae\/item-library.pdf."},{"key":"10.1016\/j.semarthrit.2026.152983_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/bmjebm-2025-113825","article-title":"Reporting guideline for the use of generative artificial intelligence tools in MEdical Research: the GAMER Statement","author":"Luo","year":"2025","journal-title":"BMJ Evid-Based Med"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152983_bib0027","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ecns.2014.07.005","article-title":"Making sense of methods and measurement: spearman-rho ranked-order correlation coefficient","volume":"10","author":"Prion","year":"2014","journal-title":"Clin Simul Nurs"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.152983_bib0028","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semarthrit.2026.152983_bib0029","article-title":"Diagnosis and early management of inflammatory arthritis","volume":"358","author":"Ledingham","year":"2017","journal-title":"BMJ"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226000727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226000727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:57:38Z","timestamp":1789667858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017226000727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":29,"alternative-id":["S0049017226000727"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.152983","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.152983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152983"}}